| Income Statement |
| Total Revenue | 2.40B |
|
| Revenues (USD) | 353.07M |
| Cost of Revenue | 312.42M |
| Gross Profit | 2.09B |
| Operating Expenses | 1.22B |
| Research and Development Expense | 430.53M |
| Selling, General and Administrative Expense | 799.58M |
| Operating Income | 863.22M |
| Income Tax Expense | 550.26M |
| Net Income | 1.95B |
| Net Income Common Stock | 1.95B |
| Net Income Common Stock (USD) | 286.31M |
| Consolidated Income | 1.94B |
| Net Income to Non-Controlling Interests | -2.76M |
| Earnings per Basic Share | 4.28 |
| Earnings per Basic Share (USD) | 0.63 |
| Earnings per Diluted Share | 4.28 |
| Earning Before Interest & Taxes (EBIT) | 2.50B |
| Earning Before Interest & Taxes (USD) | 367.31M |
| Weighted Average Shares | 908.08M |
| Weighted Average Shares Diluted | 925.61M |
| Balance Sheet |
| Cash and Equivalents | 2.58B |
| Cash and Equivalents (USD) | 379.81M |
| Investments | 22.04B |
| Investments Current | 18.36B |
| Investments Non-Current | 3.67B |
| Trade and Non-Trade Receivables | 63.85M |
| Current Assets | 21.60B |
| Property, Plant & Equipment Net | 1.49B |
| Total Assets | 26.88B |
| Debt Current | 116.67M |
| Total Debt | 216.09M |
| Current Liabilities | 5.16B |
| Debt Non-Current | 99.42M |
| Total Liabilities | 5.83B |
| Shareholders Equity | 21.05B |
| Shareholders Equity (USD) | 3.10B |
| Assets Non-Current | 5.27B |
| Total Debt (USD) | 31.81M |
| Deferred Revenue | 3.55B |
| Goodwill and Intangible Assets | 98.14M |
| Inventory | 2.16M |
| Liabilities Non-Current | 670.19M |
| Trade and Non-Trade Payables | 315.10M |
| Tax Assets | 15.17M |
| Tax Liabilities | 570.76M |
| Cash Flow |
| Net Cash Flow from Financing | -1.39B |
| Net Cash Flow / Change in Cash & Cash Equivalents | -771.54M |
| Net Cash Flow from Investing | -308.64M |
| Net Cash Flow from Operations | 944.75M |
| Effect of Exchange Rate Changes on Cash | -17.71M |